Mountain Valley MD Commencing Trials in Bangladesh, Striking Pharmaceutical Production Agreements
News provided by
Share this article
Mountain Valley MD Holdings Inc. (the
Company or
MVMD ) (CSE: MVMD) (FRA: 20MP) (OTCQB: MVMDF) is pleased to announce it is commencing husbandry animal trials under the supervision of The People s Republic of Bangladesh s Ministry of Fisheries & Livestock for the Company s injectable solubilized Ivermectin technology, Ivectosol™ 1%. We are very excited to be welcoming Mountain Valley MD to The People s Republic of Bangladesh and are proud that they have selected our country for important research projects and as a key production hub for its solubilized Ivectosol™ 1% product, stated Bangladesh s Foreign Minister H.E. Dr. A. K. Abdul Momen, M.P.